NewsRamp is a PR & Newswire Technology platform that enhances press release distribution by adapting content to align with how and where audiences consume information. Recognizing that most internet activity occurs outside of search, NewsRamp improves content discovery by programmatically curating press releases into multiple unique formats—news articles, blog posts, persona-based TLDRs, videos, audio, and Zero-Click content—and distributing this content through a network of news sites, blogs, forums, podcasts, video platforms, newsletters, and social media.
FAQ: Aditxt Inc. (NASDAQ: ADTX) 1-for-113 Reverse Stock Split Effective November 3, 2025
TL;DR
Aditxt's reverse stock split could boost share price to meet Nasdaq requirements, potentially attracting new investors and stabilizing the company's market position.
Aditxt will execute a 1-for-113 reverse stock split on November 3, 2025, converting every 113 shares into one share with fractional shares rounded up.
This financial restructuring supports Aditxt's mission to accelerate health innovations that address autoimmune diseases, cancer detection, and women's health challenges globally.
Aditxt's dramatic 1-for-113 reverse split demonstrates how companies use creative financial strategies to maintain their Nasdaq listing while pursuing medical breakthroughs.
Found this article helpful?
Share it with your network and spread the knowledge!
Aditxt Inc. is announcing a 1-for-113 reverse stock split of its common stock, effective at the opening of trading on November 3, 2025.
The reverse stock split is intended to help the company regain compliance with Nasdaq's minimum bid price requirement, as approved by stockholders on September 23, 2025.
Every 113 shares of issued and outstanding common stock will convert into one share, with fractional shares being rounded up to the nearest whole share.
The reverse stock split becomes effective at the opening of trading on November 3, 2025.
No, the stock will continue trading under the same symbol ADTX on the NASDAQ exchange.
The reverse stock split was approved by Aditxt stockholders on September 23, 2025.
Aditxt is a social innovation platform accelerating promising health innovations, currently operating four programs focused on autoimmunity, cancer and early disease detection, infectious diseases, and women's health.
Investors can view the full press release at https://ibn.fm/KgRGL and access the latest news and updates in the company's newsroom at https://ibn.fm/ADTX.
Curated from InvestorBrandNetwork (IBN)
